Evidence map›Paper›PMID 36937711›Full record

ArticleFrontiers in psychiatry2023

Individual differences in the effects of midazolam on anxiety-like behavior, learning, reward, and choice behavior in male mice.

Caio Jovita-Farias, Meagan E Follett, Behaim C Dias-Junior, Yasmim A Serra, Natali D Kisaki, Thaísa Barros-Santos, Nailton M S de Jesus, Isa R S Rodrigues, Larissa E L Macedo, Elena L A Malpezzi-Marinho and 4 more

Open access · goldFull text read
In one paragraph

Article in Frontiers in psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Ultrasonic vocal communication of negative affective states in laboratory mice.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Serotonin 5-HTFrontiers in neuroscience · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Caio Jovita-FariasDepartment of Health Sciences, Universidade Estadual de Santa Cruz, Ilhéus, BA, Brazil.
Meagan E FollettDepartment of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, MS, United States.
Behaim C Dias-JuniorDepartment of Health Sciences, Universidade Estadual de Santa Cruz, Ilhéus, BA, Brazil.
Yasmim A SerraDepartment of Health Sciences, Universidade Estadual de Santa Cruz, Ilhéus, BA, Brazil.
Natali D KisakiDepartment of Health Sciences, Universidade Estadual de Santa Cruz, Ilhéus, BA, Brazil.
Thaísa Barros-SantosDepartment of Health Sciences, Universidade Estadual de Santa Cruz, Ilhéus, BA, Brazil.
Nailton M S de JesusDepartment of Health Sciences, Universidade Estadual de Santa Cruz, Ilhéus, BA, Brazil.
Isa R S RodriguesDepartment of Health Sciences, Universidade Estadual de Santa Cruz, Ilhéus, BA, Brazil.
Larissa E L MacedoDepartment of Health Sciences, Universidade Estadual de Santa Cruz, Ilhéus, BA, Brazil.
Elena L A Malpezzi-MarinhoDepartment of Biological Sciences, Universidade Estadual de Santa Cruz, Ilhéus, BA, Brazil.
Alexandre J Oliveira-LimaDepartment of Health Sciences, Universidade Estadual de Santa Cruz, Ilhéus, BA, Brazil.
Eduardo Ary Villela MarinhoDepartment of Health Sciences, Universidade Estadual de Santa Cruz, Ilhéus, BA, Brazil.
James K RowlettDepartment of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, MS, United States.
Lais F BerroDepartment of Health Sciences, Universidade Estadual de Santa Cruz, Ilhéus, BA, Brazil.
Universidade Estadual de Santa Cruz · BRUniversity of Mississippi Medical Center · US

Funding

ANXIOLYTIC EFFECTS AND ABUSE OF BZ RECEPTOR LIGANDSR01DA011792 · NIDA · UNIVERSITY OF MISSISSIPPI MED CTR · PI ROWLETT, JAMES K · 1998 to 2024
$7.8M
Tolerance and Physical Dependence after Chronic Benzodiazepine TreatmentR01DA043204 · NIDA · UNIVERSITY OF MISSISSIPPI MED CTR · PI JAMES K ROWLETT · 2017 to 2026
$4.3M
NIDA NIH HHS R01 DA011792NIDA NIH HHS R01 DA043204
6 · The paper itself

Abstract

Introduction: The aim of the present study was to investigate the behavioral effects of the benzodiazepine midazolam in male mice, in models of anxiolysis, learning, and abuse-related effects. Methods: In a first set of experiments, male Swiss mice were submitted to the training session of a discriminative avoidance (DA) task on the elevated plus maze to evaluate anxiety-like behavior and learning after vehicle or midazolam (1, 2 or 5 mg/kg, i.g.) administration. The same animals were submitted to a conditioned place preference (CPP) protocol with midazolam (1, 2 or 5 mg/kg, i.g.). In a second experiment, outbred (Swiss) and inbred (C57BL/6) male mice were submitted to a two-bottle choice (TBC) oral midazolam drinking procedure. Animals were exposed to one sucrose bottle and one midazolam (0.008, 0.016 or 0.032 mg/ml) plus sucrose bottle. Results: Midazolam (1 and 2 mg/kg) induced anxiolytic-like effects, and all doses of midazolam prevented animals from learning to avoid the aversive closed arm during the DA training session. Assessment of midazolam reward Discussion: Our findings show that midazolam preference is a multifactorial behavior, and is not dependent solely on the emergence of therapeutic (anxiolytic-like) effects, learning impairments, or on genetic factors (inbred vs. outbred animals).

Indexed as

benzodiazepineconditioned place preferenceelevated plus mazemicemidazolamself-administration

Identifiers

PMID36937711
PMCPMC10021295
OpenAlexW4323042089

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read72
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.